NEUROBO PHARMACEUTICALS INC's ticker is NRBO and the CUSIP is 64132R107. A total of 20 filers reported holding NEUROBO PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.76 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | – | 76 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 76 | -22.4% | 0.00% | – |
| Q4 2021 | $0 | – | 98 | -30.5% | 0.00% | – |
| Q3 2021 | $0 | – | 141 | -24.6% | 0.00% | – |
| Q2 2021 | $0 | -100.0% | 187 | -72.1% | 0.00% | – |
| Q1 2021 | $2,000 | -88.2% | 670 | -79.7% | 0.00% | – |
| Q4 2020 | $17,000 | +750.0% | 3,296 | +550.1% | 0.00% | – |
| Q3 2020 | $2,000 | -83.3% | 507 | -63.8% | 0.00% | – |
| Q2 2020 | $12,000 | +50.0% | 1,399 | +140.4% | 0.00% | – |
| Q1 2020 | $8,000 | +700.0% | 582 | +665.8% | 0.00% | – |
| Q4 2019 | $1,000 | – | 76 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mount Yale Investment Advisors, LLC | 57,425 | $191,000 | 0.02% |
| FNY Investment Advisers, LLC | 10,000 | $33,000 | 0.01% |
| SG3 Management, LLC | 50,000 | $167,000 | 0.01% |
| PITCAIRN CO | 12,351 | $41,000 | 0.00% |
| Ergoteles LLC | 30,800 | $103,000 | 0.00% |
| Advisory Services Network, LLC | 8,550 | $28,000 | 0.00% |
| HRT FINANCIAL LP | 18,759 | $62,000 | 0.00% |
| UBS Group AG | 2,881 | $10,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 1,062 | $4,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 320 | $1,000 | 0.00% |